Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy ...
News Medical on MSN4d
Edaravone shows promise in targeting brain tumor stem cellsGlioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.
IFLScience on MSN1d
Revolutionary Nasal Nerve Cell "Bridges" For Treating Spinal Injuries To Begin Clinical TrialsClinical trials are about to begin for a spinal injury treatment using a "bridge" – made of stem cells from the patients’ own ...
It happens when your cerebellum, brain stem, and sometimes the membranes surrounding ... your doctor may suggest surgery to correct the functional defects and stop progressive damage to your ...
Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation ...
Hinojosa, known as "Dr. Q," says he's learned many life lessons during his nearly 40-year journey from a migrant worker to a ...
A promising ALS drug may help combat glioblastoma by targeting the cancerous stem cells that fuel tumor growth.
Eve is a joyful, adventurous two-year-old "with a smile that lights up every room"Her parents describe her as a “bright ...
CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...
SIOUX CITY (KTIV) - It is with great sadness that we announce that KTIV’s long-time Sports Director, Brad Pautsch, has died.
A police officer who defied the odds to beat locked-in syndrome following a stroke is among the thousands of patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback